Cover Image
市場調查報告書

注射型藥物輸送的全球市場:分析、預測 (2018-2025年)

Global Injectable Drug Delivery Market: Focus on Devices, Competitive Landscape and Country - Analysis and Forecast 2018-2025

出版商 BIS Research Private Limited 商品編碼 633718
出版日期 內容資訊 英文 327 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
注射型藥物輸送的全球市場:分析、預測 (2018-2025年) Global Injectable Drug Delivery Market: Focus on Devices, Competitive Landscape and Country - Analysis and Forecast 2018-2025
出版日期: 2018年05月04日 內容資訊: 英文 327 Pages
簡介

全球注射型藥物輸送市場規模,預計從2016年的167億3,000萬美元到2025年擴大到374億7,000萬美元。慢性疾病的發病率增加,同時老年人口增加,預計推動注射型藥物輸送的需求,促進全球市場的成長。

本報告提供全球注射型藥物輸送市場調查,市場概要,市場成長的各種影響因素及市場機會分析,競爭環境,各設備類型、終端用戶、給藥途徑、地區/主要國家趨勢與市場規模的變化與預測,主要企業簡介等彙整資料。

摘要整理

第1章 市場概要

第2章 市場動態

  • 概要
  • 影響分析
  • 成長推動因素
  • 阻礙成長要素
  • 市場機會

第3章 競爭情形

  • 主要市場部署、策略
  • 近幾年的市場部署策略概述分析
  • 波特的五力分析
  • 市場佔有率分析
  • 分析、預測的前提條件、限制事項

第4章 產業分析

  • 專利形勢
  • 法律上的必要條件、規定
  • 聯盟、團體、規定團體

第5章 全球注射型藥物輸送市場:各設備類型

  • 簡介
  • 無針注射器 (天然氣(氣體)型,彈簧型,其他)
  • 自動注射器 (可重複使用,拋棄式)
  • 筆型注射器 (可重複使用,拋棄式)
  • 預填充式注射器
  • 穿戴式注射器

第6章 全球注射型藥物輸送市場:各終端用戶

  • 各種終端用戶
    • 概要
    • 家庭
    • 醫院
    • 門診病人診療
    • 診療所
    • 其他
  • 全球預填充式注射器市場:各終端用戶
  • 全球的無針注射器市場:各終端用戶
  • 全球自動注射器市場:各終端用戶
  • 全球筆型注射器市場:各終端用戶

第7章 全球注射型藥物輸送市場:各給藥途徑

  • 概要
  • 各種給藥途徑 (靜脈注射,皮下注射,肌肉注射,其他)
  • 全球注射型藥物輸送市場:各給藥途徑

第8章 全球注射型藥物輸送市場:各地區

  • 地區性的情形
  • 北美
  • 歐洲
  • 亞太地區
  • 其他 (RoW)

第9章 企業簡介

  • ALKERMES PUBLIC LIMITED COMPANY
  • Antares Pharma
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Elcam Medical
  • Eli-Lilly and Company
  • Gerresheimer AG
  • Injex Pharma GmbH
  • Novartis AG
  • NOVO NORDISK
  • Pfizer, Inc.
  • PharmaJet
  • SANOFI
  • Schott AG
  • Terumo Corporation
  • Teva Pharmaceutical Industries Limited.
  • Vetter Pharma-Fertigung GmbH & Co. KG
  • West Pharmaceutical Services, Inc.
  • Ypsomed Holding AG

第10章 調查範圍、手法

目錄
Product Code: BH056A

The global injectable drug delivery market was estimated at $16.73 billion in 2016 and is estimated to grow over $37.47 billion by 2025. The rise in the geriatric population along with the increased prevalence of chronic diseases is expected to boost the demand for the injectable drug delivery devices and drive growth of the global market.

The global healthcare scenario is changing rapidly owing to the rising geriatric population as well as the increasing prevalence of diseases. As per the WHO statistics, the global elderly population (aged 65 years and over) was 562 million in 2012 and it increased by 55 million in 2015. The rising prevalence of various chronic and autoimmune diseases had a profound effect on the global healthcare scenario. The WHO further states that the global prevalence of diabetes, which is one of the chronic diseases, increased to 8.5% in adults over the age of 18 years in 2014, from 4.7% in 1980. These factors have led to an escalated demand for improved treatment and diagnostic services as diagnosis is the very first and crucial step of treating any ailment. The treatment of these chronic diseases involves the frequent administration of drugs, especially biologics and biosimilars. Initially hypodermic needles and syringes were used. Nowadays novel ways to administer drug have been developed like needle free injectors, autoinjectors, pen injectors & prefilled syringes.

The injectable drug delivery devices market includes devices, such as auto-injectors, pen injectors and needle free injection technology. The market consists of various device products which can be used for various routes of administration, such as intravenous, subcutaneous/ intradermal, intra-peritoneal, intra-muscular and others.

These devices are being used for the administration of various medications especially for the biological products and proteins, such as insulin. The market analysis includes an in-depth examination of the key ecosystem players, and the key strategies and developments taking place in this market. Additionally, it includes market dynamics (market drivers, opportunities, and challenges), and industry analysis.

The purpose of the study is to gain a holistic view of the global injectable drug delivery market in terms of various factors influencing it, such as recent trends, technological advancements, and regulatory aspects of the market. The scope of this report is centered upon conducting a detailed study of the solutions allied with the injectable drug delivery market. The market has been segmented into ‘devices', ‘end-user', 'route of administration' and ‘geographical regions'. The report offers the reader with an opportunity to unlock comprehensive insights with respect to the market and helps in forming well informed strategic decisions. The research uncovers some of the significant parameters that must be taken into consideration before entering the market.

This research report aims at answering questions related to various aspects of the global market with the help of the key factors driving the market, threats that can possibly inhibit the overall market growth, and the current growth opportunities that are going to shape the future trajectory of the market expansion. The study considers the growth-share matrix model for a comprehensive study of the global injectable drug delivery market, and assesses the factors governing the same.

The answers to the following key questions can be derived from this report:

  • What are the major market drivers, challenges, and opportunities in the global injectable drug delivery market?
  • How did the needle less technology evolve, and what is its scope in the future?
  • What were the market shares of the leading segments, and sub-segments of the global injectable drug delivery market in 2016 and what will be the value after 2025?
  • How will each segment of the global injectable drug delivery market grow during the forecast period, and what will be the revenue generated by each of the segments by the end of 2025?
  • What are the influencing factors that may affect the market share of the key players?
  • What are the key developmental strategies implemented by the key players to stand out in this market?
  • What will be the growth rate of the pen injectors and autoinjector devices during the forecast period?
  • Which product segment is expected to register the highest CAGR for the injectable drug delivery market?
  • How will the homecare segment among the end users grow from 2018 to 2025?
  • Which geographical location will contribute to the highest sales of the injectable drug delivery devices during the forecast period?

The key players for the market are Antares Pharma, Becton Dickinson and Company, Baxter International AG, Elcam Medical, Eli-Lilly, Sanofi, Gerresheimer AG, PharmaJet, Injex Pharma, and Schott AG, among others.

Table of Contents

Executive Summary

1. Market Overview

  • 1.1. Introduction
  • 1.2. History of Injectable Drug Delivery Systems
  • 1.3. Onset of Prefilled-Syringes
  • 1.4. Introduction of Needle-Free Technology
  • 1.5. Advantages of Prefilled Syringes Over Traditional Vial & Syringe System
  • 1.6. Prefilled Syringes: Manufacturing and Packaging Challenges
  • 1.7. Components of Prefilled Syringes
  • 1.8. Benefits of Prefilled Syringes to the Pharmaceutical Companies
  • 1.9. Rising Prevalence of Diabetes
  • 1.10. Diabetes Prevalence in Different Countries (2017 Estimates)
  • 1.11. Rising Prevalence of Diabetes and Use of Insulin Delivery Devices

2. Market Dynamics

  • 2.1. Overview
  • 2.2. Impact Analysis
  • 2.3. Market Drivers
  • 2.4. Market Restraints
  • 2.5. Market Opportunities

3. Competitive Landscape

  • 3.1. Key Developments & Strategies
  • 3.2. Recent Market Development Strategy Snapshot Analysis
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Bargaining Power of Buyers
    • 3.3.3. Threat of New Entrant
    • 3.3.4. Threat of Substitute
    • 3.3.5. Intensity of Competitive Rivalry
  • 3.4. Market Share Analysis
    • 3.4.1. Market Share Analysis, Pen and Auto Injectors
    • 3.4.2. Market Share Analysis, Prefilled
    • 3.4.3. Market Share Analysis, Needle Free Injectors
  • 3.5. Assumptions & Limitations for Analysis & Forecast of the Global Injectable Drug Delivery Market

4. Industry Insights

  • 4.1. Patent Landscape
  • 4.2. Legal Requirements and Regulations
  • 4.3. Consortiums, Associations and Regulatory Bodies

5. Global Injectable Drug Delivery Market, By Device Type

  • 5.1. Introduction
  • 5.2. Needle Free Injectors (Gas-based, Spring-Based and Others)
    • 5.2.1. Global Needle Free Injector Market, By Region
  • 5.3. Auto-Injectors (Reusable & Disposable)
    • 5.3.1. Global Auto-Injectors Market, By Region
  • 5.4. Pen Injectors (Reusable & Disposable)
    • 5.4.1. Pen Injectors for Insulin
    • 5.4.2. Global Pen Injectors Market, By Region
  • 5.5. Prefilled Syringes
    • 5.5.1. Global Prefilled Syringe Market, By Region
    • 5.5.2. Glass Prefilled Syringes
    • 5.5.3. Plastic Prefilled Syringes
    • 5.5.4. Single Chamber Prefilled Syringes
      • 5.5.4.1. Advantages of Hyaluronic Method of Single Chamber Prefilled Syringes Filling
    • 5.5.5. Dual Chamber Prefilled Syringes
      • 5.5.5.1. Some of the Marketed Dual Chambered Prefilled Syringes
    • 5.5.6. Conventional Prefilled Syringe
    • 5.5.7. Some of the lyophilized drugs which are used in prefilled syringe format
    • 5.5.8. Safety Prefilled Syringes
      • 5.5.8.1. Marketed Prefilled Safety Syringes
    • 5.5.9. Customized Prefilled Syringes
  • 5.6. Wearable Injectors (Qualitative)

6. Global Injectable Drug Delivery Market, By End User

  • 6.1. Different Types of End User
    • 6.1.1. Overview
    • 6.1.2. Home Based
    • 6.1.3. Hospital
    • 6.1.4. Ambulatory Care
    • 6.1.5. Clinics/Physician Offices
    • 6.1.6. Others
  • 6.2. Global Prefilled Syringes Market, by End Users
  • 6.3. Global Needle Free Injector Market, by End Users
  • 6.4. Global Auto-Injectors Market, by End Users
  • 6.5. Global Pen Injection Market, by End Users

7. Global Injectable Drug Delivery Market, By Route Of Administration

  • 7.1. Overview
  • 7.2. Different Route of Administration (Intravenous, Subcutaneous, intramuscular and Others)
  • 7.3. Global Injectable Drug Delivery Market, By Route of Administration

8. Global Injectable Drug Delivery Market, By Region

  • 8.1. Geographical Scenario
  • 8.2. North America
    • 8.2.1. The U.S.
  • 8.2.2. Canada
  • 8.3. Europe
    • 8.3.1. The U.K.
    • 8.3.2. Germany
    • 8.3.3. France
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Netherlands
    • 8.3.7. Switzerland
    • 8.3.8. Belgium
    • 8.3.9. Poland
    • 8.3.10. Austria
    • 8.3.11. Turkey
    • 8.3.12. Rest of Europe
  • 8.4. Asia Pacific (APAC)
    • 8.4.1. Japan
    • 8.4.2. China
    • 8.4.3. Australia
    • 8.4.4. South Korea
    • 8.4.5. India
    • 8.4.6. Malaysia
    • 8.4.7. Indonesia
    • 8.4.8. Rest of Asia Pacific
    • 8.5. Latin America
    • 8.5.1. Brazil
    • 8.5.2. Mexico
    • 8.5.3. Argentina
    • 8.5.4. Rest of Latin America
  • 8.6. Rest of the World (RoW)
    • 8.6.1. K.S.A
    • 8.6.2. Russia
    • 8.6.3. South Africa
    • 8.6.4. RoW

9. Company Profiles

  • 9.1. ALKERMES PUBLIC LIMITED COMPANY
    • 9.1.1. Overview
    • 9.1.2. Product Portfolio
    • 9.1.3. Financials
      • 9.1.3.1. Financial Summary
    • 9.1.4. SWOT Analysis
  • 9.2. Antares Pharma
    • 9.2.1. Overview
    • 9.2.2. Product Portfolio
    • 9.2.3. Financials
      • 9.2.3.1. Financial Summary
    • 9.2.4. SWOT Analysis
  • 9.3. Baxter International Inc.
    • 9.3.1. Overview
    • 9.3.2. Product Portfolio
    • 9.3.3. Financials
      • 9.3.3.1. Financial Summary
    • 9.3.4. SWOT Analysis
  • 9.4. Becton, Dickinson and Company
    • 9.4.1. Overview
    • 9.4.2. Product Portfolio
    • 9.4.3. Financials
      • 9.4.3.1. Financial Summary
    • 9.4.4. SWOT Analysis
  • 9.5. Elcam Medical
    • 9.5.1. Overview
    • 9.5.2. Product Portfolio
    • 9.5.3. Corporate Summary
    • 9.5.4. SWOT Analysis
  • 9.6. Eli-Lilly and Company
    • 9.6.1. Overview
    • 9.6.2. Product Portfolio
    • 9.6.3. Financials
      • 9.6.3.1. Financial Summary
    • 9.6.4. SWOT Analysis
  • 9.7. Gerresheimer AG
    • 9.7.1. Overview
    • 9.7.2. Product Portfolio
    • 9.7.3. Financials
      • 9.7.3.1. Financial Summary
    • 9.7.4. SWOT Analysis
  • 9.8. Injex Pharma GmbH
    • 9.8.1. Overview
    • 9.8.2. Product Portfolio
    • 9.8.3. Corporate Summary
    • 9.8.4. SWOT Analysis
  • 9.9. Novartis AG
    • 9.9.1. Overview
    • 9.9.2. Product Portfolio
    • 9.9.3. Financials
      • 9.9.3.1. Financial Summary
    • 9.9.4. SWOT Analysis
  • 9.10. NOVO NORDISK
    • 9.10.1. Overview
    • 9.10.2. Product Portfolio
    • 9.10.3. Financials
      • 9.10.3.1. Financial Summary
    • 9.10.4. SWOT Analysis
  • 9.11. Pfizer, Inc.
    • 9.11.1. Overview
    • 9.11.2. Product Portfolio
    • 9.11.3. Financials
      • 9.11.3.1. Financial Summary
    • 9.11.4. SWOT Analysis
  • 9.12. PharmaJet
    • 9.12.1. Overview
    • 9.12.2. Product Portfolio
    • 9.12.3. Corporate Summary
    • 9.12.4. SWOT Analysis
  • 9.13. SANOFI
    • 9.13.1. Overview
    • 9.13.2. Product Portfolio
    • 9.13.3. Financials
      • 9.13.3.1. Financial Summary
    • 9.13.4. SWOT Analysis
  • 9.14. Schott AG
    • 9.14.1. Overview
    • 9.14.2. Product Portfolio
    • 9.14.3. Financials
      • 9.14.3.1. Financial Summary
    • 9.14.4. SWOT Analysis
  • 9.15. Terumo Corporation
    • 9.15.1. Overview
    • 9.15.2. Product Portfolio
    • 9.15.3. Financials
      • 9.15.3.1. Financial Summary
    • 9.15.4. SWOT Analysis
  • 9.16. Teva Pharmaceutical Industries Limited.
    • 9.16.1. Overview
    • 9.16.2. Product Portfolio
    • 9.16.3. Financials
      • 9.16.3.1. Financial Summary
    • 9.16.4. SWOT Analysis
  • 9.17. Vetter Pharma-Fertigung GmbH & Co. KG
    • 9.17.1. Overview
    • 9.17.2. Product Portfolio
    • 9.17.3. Corporate Summary
    • 9.17.4. SWOT Analysis
  • 9.18. West Pharmaceutical Services, Inc.
    • 9.18.1. Overview
    • 9.18.2. Product Portfolio
    • 9.18.3. Financials
      • 9.18.3.1. Financial Summary
    • 9.18.4. SWOT Analysis
  • 9.19. Ypsomed Holding AG
    • 9.19.1. Overview
    • 9.19.2. Product Portfolio
    • 9.19.3. Financials
      • 9.19.3.1. Financial Summary
    • 9.19.4. SWOT Analysis

10. Report Scope & Methodology

  • 10.1. Scope of the Report
  • 10.2. Market Segmentation
  • 10.3. Research Methodology
    • 10.3.1. Primary Research
    • 10.3.2. Secondary Research
    • 10.3.3. Key Data Points From Primary Sources
    • 10.3.4. Data Triangulation
    • 10.3.5. Top-Down Approach (Segmental Analysis)
    • 10.3.6. Bottom-Up Approach (Segmental Analysis)
  • 10.4. Assumptions and Limitations

List of Tables

  • 1. Key Players in the Market
  • 2. Impact of Market Drivers
  • 3. Impact of Market Restraints
  • 4. Components of Prefilled Syringes
  • 5. Number of Diabetics Worldwide and As Per region In 2017 and 2045 (20-79 years
  • 6. Comparative Prevalence of Diabetes in Different Countries (20-79 years)
  • 7. Impact Analysis of Market Dynamics
  • 8. Region-wise Percentage of Total Population Aged 65 years & Above: 2015 & 2030
  • 9. Factors Affecting the Bargaining Power of Buyer
  • 10. Factors Affecting Threat of New Entrant
  • 11. Factors Affecting the Threat of Substitute
  • 12. Factors Affecting the Intensity of Competitive Rivalry
  • 13. Patent Landscape
  • 14. Consortiums, Associations and Regulatory Bodies
  • 15. List of Some of the marketed products
  • 16. Different types of Insulin Pen Injectors in Market
  • 17. Regional Pen Injectors Market, By Value, 2016-2025 ($Million)
  • 18. Regional Prefilled Syringe Market, By Value, 2016-2025 ($Million)
  • 19. Regional Prefilled Syringe Market, By Volume, 2016-2025 (Million Units)
  • 20. List of Some Dual Chamber Prefilled Syringes
  • 21. List of Some Lyophilized Drugs which are used in Prefilled Syringe Format
  • 22. List of Some Recently Marketed Prefilled Safety Syringes Technologies
  • 23. Global Drug Delivery Market By Route of Admistration (2016-2025)
  • 24. Percentages of Population Aged 60 Years and Above
  • 25. ALKERMES PUBLIC LIMITED COMPANY: Overview
  • 26. Antares Pharma: Overview
  • 27. Baxter International Inc.: Overview
  • 28. Becton Dickinson and Company: Overview
  • 29. Elcam Medical: Overview
  • 30. Eli-Lilly and Company: Overview
  • 31. Gerresheimer AG: Overview
  • 32. Injex Pharma GmbH: Overview
  • 33. Novartis AG: Overview
  • 34. NOVO NORDISK: Overview
  • 35. Pfizer, Inc.: Overview
  • 36. PharmaJet: Overview
  • 37. SANOFI: Overview
  • 38. Schott AG: Overview
  • 39. Terumo Corporation: Overview
  • 40. Teva Pharmaceuticals Industries Limited.: Overview
  • 41. Vetter Pharma-Fertigung GmbH & Co. KG: Overview
  • 42. West Pharmaceutical Services, Inc.: Overview
  • 43. Ypsomed Holding AG: Overview

List of Figures

  • 1. Chronic Conditions: Key Statistics: 2016
  • 2. The Global Injectable Drug Delivery Market ($Million)
  • 3. Types of Injector Devices
  • 4. Global Injectable Drug Delivery Market, by Device, 2016
  • 5. Global Injectable Drug Delivery Market, by Devices, 2025
  • 6. Global Injectable Drug Delivery Market, by End Users, 2016
  • 7. Global Injectable Drug Delivery Market, by End Users, 2025
  • 8. Global Injectable Drug Delivery Market, by Route of Administration, 2016
  • 9. Global Injectable Drug Delivery Market, by Route of Administration, 2025
  • 10. Global Injectable Drug Delivery Market, by Region, 2016
  • 11. Global Injectable Drug Delivery Market, by Region, 2025
  • 12. Various Types of Injectable Drug Delivery Devices
  • 13. Limitations of Hypodermic Needles
  • 14. Key Milestones in History of Syringes
  • 15. The Key Advantages of Needle-Free Technology
  • 16. Advancements in Injectable Drug Delivery Technology
  • 17. Advantages of Prefilled Syringes
  • 18. Diabetes Statistics
  • 19. Drivers Restraints and Opportunities
  • 20. PER DAY COST SAVINGS VS. HOSPITAL
  • 21. Share of the Key Strategies in the Global Injectable Drug Delivery Market
  • 22. Porter's Five Forces Analysis
  • 23. Global Injectable Drug Delivery Market, 2016-2025 ($ Million)
  • 24. Segmentation of Global Injectable Drug Delivery Market, By Device Type
  • 25. Global Injectable Drug Delivery Market, By Device Type, 2016-2025 ($Million)
  • 26. Global Needle Free Injector Market, 2016-2025 ($ Million)
  • 27. Global Needle Free Injector Market, by type, 2016-2025 ($Million)
  • 28. Advantages and Disadvantages of Needle Free Injectors
  • 29. Types of Needle Free Injectors
  • 30. Global Gas-Based Needle-Free Injectors Market, 2016-2025 ($Million)
  • 31. Global Spring-Based Needle-Free Injectors Market, 2016-2025 ($Million)
  • 32. Global Others Needle-Free Injectors Market, 2016-2025 ($Million)
  • 33. Global Auto-Injector Market, 2016-2025 ($ Million)
  • 34. Global Auto-injector Market, by Type, 2016-2025 ($Million)
  • 35. Types of Pen Injectors
  • 36. Global Pen Injector Market, 2016-2025 ($ Million)
  • 37. Global Pen Injector Market, by type, 2016-2025 ($Million)
  • 38. Global Prefilled Syringe Market, By Value, 2016-2025 ($Million)
  • 39. Global Prefilled Syringe Market, By Volume, 2016-2025 (Million)
  • 40. Global Glass Prefilled Syringes Market, By Value, 2016-2025 ($ Millions)
  • 41. Global Glass Prefilled Syringe Market, By Volume, 2016-2025 (Million)
  • 42. Global Plastic Prefilled Syringe Market, By Value, 2016-2025 ($Million)
  • 43. Global Plastic Prefilled Syringe Market, By Volume, 2016-2025 (Million)
  • 44. Global Single Chambered Prefilled Syringe Market, By Value, 2016-2025 ($Million)
  • 45. Global Plastic Prefilled Syringe Market, By Volume, 2016-2025 (Million)
  • 46. Global Dual Chambered Prefilled Syringe Market, By Value, 2016-2025 ($Million)
  • 47. Global Dual Chambered Prefilled Syringe Market, By Volume, 2016-2025 (Million)
  • 48. Global Customized Prefilled Syringes Market, by Value and Volume, 2016-2025 ($ Millions)
  • 49. Global Customized Prefilled Syringe Market, By Volume, 2016-2025 (Million)
  • 50. Types of End Users
  • 51. Global Injectable Drug Delivery Market, by End Users (2016-2025)
  • 52. Global Injectable Drug Delivery Market, by Home Based Treatment (2016-2025)
  • 53. Global Injectable Drug Delivery Market, by Hospital (2016-2025)
  • 54. Global Injectable Drug Delivery Market, by Ambulatory Care (2016-2025)
  • 55. Global Injectable Drug Delivery Market, by Clinics/Physician Offices (2016-2025)
  • 56. Global Injectable Drug Delivery Market, by Others (2016-2025)
  • 57. Global Prefilled Syringes Market, by End Users (2016-2025)
  • 58. Global Needle Free Market, by End Users 2016-2025)
  • 59. Global Auto- Injectors Market, by End Users (2016-2025)
  • 60. Global Pen Injection Market, by End Users (2016-2025)
  • 61. Different Routes of Administration
  • 62. Global Drug Delivery Market By Route of Admistration (2016-2025)
  • 63. Global Injectable Drug Delivery Market, By Region
  • 64. Global Injectable Drug Delivery Market, by region, 2016-2025 ($Million)
  • 65. North America Injectable Drug Delivery Market, 2016-2025 ($Million)
  • 66. North America Injectable Drug Delivery Market, by Country, 2016-2025 ($Million)
  • 67. The U.S. Injectable Drug Delivery Market, 2016-2025 ($million)
  • 68. The U.S. Injectable Drug Delivery Market, By Device, 2016-2025 ($million)
  • 69. Canada Injectable Drug Delivery Market, 2016-2025 ($million)
  • 70. Canada Injectable Drug Delivery Market, By Device 2016-2025 ($million)
  • 71. Europe Injectable Drug Delivery Market, 2016-2025 ($Million)
  • 72. The U.K. Injectable Drug Delivery Market, 2016-2025 ($million)
  • 73. The U.K. Injectable Drug Delivery Market, By Device, 2016-2025 ($million)
  • 74. Germany Injectable Drug Delivery Market, 2016-2025 ($million)
  • 75. Germany Injectable Drug Delivery Market, By Device, 2016-2025 ($million)
  • 76. France Injectable Drug Delivery Market, 2016-2025 ($million)
  • 77. France Injectable Drug Delivery Market, By Device, 2016-2025 ($million)
  • 78. Italy Injectable Drug Delivery Market, 2016-2025 ($million)
  • 79. Italy Injectable Drug Delivery Market, By Device, 2016-2025 ($million)
  • 80. Spain Injectable Drug Delivery Market, 2016-2025 ($million)
  • 81. Spain Injectable Drug Delivery Market, By Device, 2016-2025 ($million)
  • 82. Netherlands Injectable Drug Delivery Market, 2016-2025 ($million)
  • 83. Netherlands Injectable Drug Delivery Market, By Device, 2016-2025 ($million)
  • 84. Switzerland Injectable Drug Delivery Market, 2016-2025 ($million)
  • 85. Switzerland Injectable Drug Delivery Market, By Device, 2016-2025 ($million)
  • 86. Belgium Injectable Drug Delivery Market, 2016-2025 ($million)
  • 87. Belgium Injectable Drug Delivery Market, By Device, 2016-2025 ($million)
  • 88. Poland Injectable Drug Delivery Market, 2016-2025 ($million)
  • 89. Poland Injectable Drug Delivery Market, By Device, 2016-2025 ($million)
  • 90. Austria Injectable Drug Delivery Market, 2016-2025 ($million)
  • 91. Austria Injectable Drug Delivery Market, By Device, 2016-2025 ($million)
  • 92. Turkey Injectable Drug Delivery Market, 2016-2025 ($million)
  • 93. Turkey Injectable Drug Delivery Market, By Device, 2016-2025 ($million)
  • 94. Rest of Europe Injectable Drug Delivery Market, 2016-2025 ($million)
  • 95. Rest of Europe Injectable Drug Delivery Market, By Device, 2016-2025 ($million)
  • 96. Asia Pacific Injectable Drug Delivery Market, 2016-2025 ($Million)
  • 97. Japan Injectable Drug Delivery Market, by value, 2016-2025 ($million)
  • 98. Japan Injectable Drug Delivery Market, by Devices 2016-2025 ($million)
  • 99. China Injectable Drug Delivery Market, by value, 2016-2025 ($million)
  • 100. China Injectable Drug Delivery Market, by Devices 2016-2025 ($million)
  • 101. Australia Injectable Drug Delivery Market, by value, 2016-2025 ($million)
  • 102. Australia Injectable Drug Delivery Market, by Devices 2016-2025 ($million)
  • 103. South Korea Injectable Drug Delivery Market, by value, 2016-2025 ($million)
  • 104. South Korea Injectable Drug Delivery Market, by Devices 2016-2025 ($million)
  • 105. India Injectable Drug Delivery Market, by value, 2016-2025 ($million)
  • 106. India Injectable Drug Delivery Market, by Devices 2016-2025 ($million)
  • 107. Malaysia Injectable Drug Delivery Market, by value, 2016-2025 ($million)
  • 108. Malaysia Injectable Drug Delivery Market, by Devices 2016-2025 ($million)
  • 109. Indonesia Injectable Drug Delivery Market, by value, 2016-2025 ($million)
  • 110. Indonesia Injectable Drug Delivery Market, by Devices 2016-2025 ($million)
  • 111. Rest of Asia Pacific Injectable Drug Delivery Market, by value, 2016-2025 ($million)
  • 112. Rest of Asia Pacific Injectable Drug Delivery Market, by Devices 2016-2025 ($million)
  • 113. Prevalence of Diabetes in Brazil & Mexico
  • 114. Latin America Injectable Drug Delivery Market, 2016-2025 ($Million)
  • 115. Brazil Injectable Drug Delivery Market, by value, 2016-2025 ($million)
  • 116. Brazil Injectable Drug Delivery Market, by Devices 2016-2025 ($million)
  • 117. Mexico Injectable Drug Delivery Market, by value, 2016-2025 ($million)
  • 118. Mexico Injectable Drug Delivery Market, by Devices 2016-2025 ($million)
  • 119. Argentina Injectable Drug Delivery Market, by value, 2016-2025 ($million)
  • 120. Argentina Injectable Drug Delivery Market, by Devices 2016-2025 ($million)
  • 121. Rest of Latin America Injectable Drug Delivery Market, by value, 2016-2025 ($million)
  • 122. Rest of Latin America Injectable Drug Delivery Market, by Devices 2016-2025 ($million)
  • 123. RoW Injectable Drug Delivery Market, 2016-2025 ($Million)
  • 124. K.S.A Injectable Drug Delivery Market, by value, 2016-2025 ($million)
  • 125. K.S.A Injectable Drug Delivery Market, by Devices 2016-2025 ($million)
  • 126. Russia Injectable Drug Delivery Market, by value, 2016-2025 ($million)
  • 127. Russia Injectable Drug Delivery Market, by value, 2016-2025 ($million)
  • 128. South Africa Injectable Drug Delivery Market, by value, 2016-2025 ($million)
  • 129. South Africa Injectable Drug Delivery Market, by Devices 2016-2025 ($million)
  • 130. RoW Injectable Drug Delivery Market, by value, 2016-2025 ($million)
  • 131. RoW Injectable Drug Delivery Market, by Devices 2016-2025 ($million)
  • 132. ALKERMES PUBLIC LIMITED COMPANY: Product Portfolio
  • 133. ALKERMES PUBLIC LIMITED COMPANY: Overall Financials (2015-2017)
  • 134. ALKERMES PUBLIC LIMITED COMPANY: Revenue by Region (2015-2017)
  • 135. ALKERMES PUBLIC LIMITED COMPANY: SWOT Analysis
  • 136. Antares Pharma: Overall Product Portfolio
  • 137. Antares Pharma: Overall Financials (2015-2017)
  • 138. Antares Pharma: Product Sales by Geographic Location (2015-2017)
  • 139. Antares Pharma: SWOT Analysis
  • 140. Baxter International Inc.: Product Portfolio
  • 141. Baxter International Inc.: Overall Financials (2015-2017)
  • 142. Baxter International Inc.: Revenue by Global Business Units(2015-2017)
  • 143. Baxter International Inc.: Revenue by Geographical Location (2015-2017)
  • 144. Baxter International Inc.: SWOT Analysis
  • 145. Becton Dickinson and Company : Overall Product Portfolio
  • 146. Becton, Dickinson and Company : Overall Financials (2015-2017)
  • 147. Becton, Dickinson and Company: Product Sales by Region (2015-2017)
  • 148. Becton, Dickinson and Company: Revenue by Business Segment (2015-2017)
  • 149. Becton, Dickinson and Company: Revenue by Sub-Segment (2015-2017)
  • 150. Becton Dickinson and Company: SWOT Analysis
  • 151. Elcam Medical: Product Portfolio
  • 152. Elcam Medical: SWOT Analysis
  • 153. Eli-Lilly and Company: Overall Product Portfolio
  • 154. Eli-Lilly and Company: Overall Financials (2014-2017)
  • 155. Eli-Lilly and Company : Revenue by Business Segment (2014-2017)
  • 156. Eli-Lilly and Company: Revenue by Geography (2014-2017)
  • 157. Eli-Lilly and Company: SWOT Analysis
  • 158. Gerresheimer AG: Overall Product Portfolio
  • 159. Gerresheimer AG: Overall Financials (2015-2017)
  • 160. Gerresheimer AG: Revenue by Business Division (2015-2017)
  • 161. Gerresheimer AG: Revenue by Geographical Location (2015-2017)
  • 162. Gerresheimer AG: SWOT Analysis
  • 163. Injex Pharma GmbH: Product Portfolio
  • 164. Injex Pharma GmbH: SWOT Analysis
  • 165. Novartis AG.: Overall Product Portfolio
  • 166. Novartis AG : Overall Financials (2014-2017)
  • 167. Novartis AG : Revenue by Region (2014-2017)
  • 168. Novartis AG: Revenue by Business Segment (2014-2015)
  • 169. Novartis AG: Revenue by Business Segment (2016-2017)
  • 170. Novartis AG: SWOT Analysis
  • 171. NOVO NORDISK: Overall Product Portfolio
  • 172. NOVO NORDISK: Overall Financials (2015-2017)
  • 173. NOVO NORDISK: Revenue by Business Segment (2015-2017)
  • 174. NOVO NORDISK: Product Sales by Geographical Areas (2015-2017)
  • 175. NOVO NORDISK: SWOT Analysis
  • 176. Pfizer, Inc.: Product Portfolio
  • 177. Pfizer Injectables: Product Portfolio
  • 178. Pfizer Inc. : Overall Financials (2015-2017)
  • 179. Pfizer Inc. : Revenue by Business Segment (2015-2017)
  • 180. Pfizer, Inc. : Revenue by Geography (2015-2017)
  • 181. Pfizer, Inc. : SWOT Analysis
  • 182. PharmaJet: Product Portfolio
  • 183. PharmaJet: SWOT Analysis
  • 184. SANOFI: Overall Product Portfolio
  • 185. SANOFI: Overall Financials (2015-2017)
  • 186. SANOFI: Revenue by Business Segment (2015)
  • 187. SANOFI: Revenue by Business Segment (2016-2017)
  • 188. SANOFI: Revenue by Geography (2016-2017)
  • 189. SANOFI: Revenue by Geography (2015)
  • 190. SANOFI: SWOT Analysis
  • 191. Schott AG: Overall Product Portfolio
  • 192. Schott AG: Overall Financials (2015-2017)
  • 193. Schott AG: Revenue by Geographical Location (2016-2017)
  • 194. Schott AG: Revenue by Geographical Location(2015)
  • 195. Schott AG: SWOT Analysis
  • 196. Terumo Corporation: Overall Product Portfolio
  • 197. Terumo Pharmaceutical Solutions: Product Portfolio
  • 198. Terumo Corporation: Overall Financials (2015-2017)
  • 199. Terumo Corporation: Revenue by Business Segment (2015-2017)
  • 200. Terumo Corporation: Net Revenue by Region (2015-2017)
  • 201. Terumo Corporation: SWOT Analysis
  • 202. Teva Pharmaceuticals Industries Limited: Product Portfolio
  • 203. Teva Pharmaceuticals Industries Limited.: Overall Financials (2015-2017)
  • 204. Teva Pharmaceuticals Industries Limited.: Revenue by Business Segments (2015-2017)
  • 205. Teva Pharmaceuticals Industries Limited.: Revenue by Geographical Location (2015-2017)
  • 206. Teva Pharmaceuticals Industries Limited.: SWOT Analysis
  • 207. Vetter Pharma-Fertigung GmbH & Co. KG: Product Portfolio
  • 208. Vetter Pharma-Fertigung GmbH & Co. KG: SWOT Analysis
  • 209. West Pharmaceutical Services, Inc.: Overall Product Portfolio
  • 210. West Pharmaceutical Services, Inc.: Overall Financials (2015-2017)
  • 211. West Pharmaceutical Services, Inc.: Revenue by Business Segment (2015-2017)
  • 212. West Pharmaceutical Services, Inc.: Revenue by Geographical Location (2015-2017)
  • 213. West Pharmaceutical Services, Inc.: SWOT Analysis
  • 214. Ypsomed Holding AG: Product Portfolio
  • 215. Ypsomed Holding AG: Overall Financials (2015-2017)
  • 216. Ypsomed Holding AG: Revenue by Business Segments (2015-2017)
  • 217. Ypsomed Holding AG: Revenue by Geographical Location (2015-2017)
  • 218. Ypsomed Holding AG: SWOT Analysis
  • 219. Global Injectable Drug Delivery Market Segmentation
Back to Top